EuroSCORE II: Current limitations and physiological gaps in risk stratification
Experimental Physiology · 2026-03 · 111 (3) · 1069-1080
DOI: 10.1113/ep092900 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Experimental Physiology, online erschienen am 22.07.2025. Verfasst von Jing Yong Ng und 7 weiteren Autor:innen. Beteiligte Einrichtung: Barts Heart Centre, St Bartholomew's Hospital, London, UK. Hauptthemen laut MEDLINE: Cardiac Surgical Procedures. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Royal Society Wolfson Research Fellowship.
Abstract (Originalsprache)
Risk stratification remains critical in cardiac surgery, enabling clinicians to predict adverse outcomes and guide perioperative management. The European System for Cardiac Operative Risk Evaluation (EuroSCORE) II, introduced in 2011, incorporates 18 key variables to provide an evidence‐based approach to risk assessment. However, evolving surgical techniques, changing patient demographics, and emerging evidence reveal limitations in the model's predictive capabilities. Important factors such as frailty, race, liver dysfunction, left ventricular dimensions, and advanced cardiac function metrics are not incorporated, reducing its accuracy in diverse and high‐risk populations. Additionally, the model does not fully account for key conditions, such as infective endocarditis, where high‐risk features like embolic events and abscesses significantly impact surgical outcomes. Simplified categorisation of procedures and the binary assessment of coronary artery disease overlook critical complexities, such as lesion severity and procedural variability. Advanced parameters like global longitudinal strain (GLS), SYNTAX, and Model for End‐Stage Liver Disease (MELD) scores could enhance the model's granularity and predictive power. Furthermore, integrating machine learning into future iterations of EuroSCORE offers the potential to capture non‐linear interactions and continuously refine predictions. These updates could pave the way for a ‘EuroSCORE III’ better aligned with modern surgical practices, offering improved precision in risk stratification, more personalised clinical decision‐making and optimised patient outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Barts Heart Centre, St Bartholomew's Hospital, London, UK.
- Barts Health NHS Trust, Milton Keynes University Hospital, Eaglestone, Milton Keynes, UK.
- Hull York Medical School, University of York, York, UK.
- Neurovascular Research Laboratory, Faculty of Life Sciences and Education, University of South Wales, Cardiff, UK.
- William Harvey Research Institute, Queen Mary University of London, London, UK.
ORCID-Profile: Jing Yong Ng, Marsioleda Kemberi, Matti Jubouri, Damian M Bailey, Mohamad Bashir
Förderung
- Royal Society Wolfson Research Fellowship
Zitieren
APA
Ng, J. Y., Tan, E. F., Kemberi, M., Urgesi, E., Jubouri, M., Bailey, D. M., Bashir, M., & Awad, W. I. (2026). EuroSCORE II: Current limitations and physiological gaps in risk stratification. Experimental Physiology, 111(3), 1069-1080. https://doi.org/10.1113/ep092900
Vancouver
Ng JY, Tan EF, Kemberi M, Urgesi E, Jubouri M, Bailey DM, et al. EuroSCORE II: Current limitations and physiological gaps in risk stratification. Experimental Physiology. 2026;111(3):1069-1080. doi:10.1113/ep092900
BibTeX
@article{Ng2026,
author = {Ng, Jing Yong and Tan, Eu Fon and Kemberi, Marsioleda and Urgesi, Eduardo and Jubouri, Matti and Bailey, Damian M and Bashir, Mohamad and Awad, Wael I},
title = {EuroSCORE II: Current limitations and physiological gaps in risk stratification},
journal = {Experimental Physiology},
year = {2026},
volume = {111},
number = {3},
pages = {1069--1080},
doi = {10.1113/ep092900}
}
EUVIMED